First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
| Image |  |
|---|---|
| Description | scientific article published on 22 January 2020 |
| Author/s |
author: Joaquin Martinez-Lopez Philippe Moreau Katja Weisel Jesús San Miguel |
| Publication date | January 22, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |